Bengt Westermark

36.1k total citations · 7 hit papers
340 papers, 29.1k citations indexed

About

Bengt Westermark is a scholar working on Molecular Biology, Oncology and Cancer Research. According to data from OpenAlex, Bengt Westermark has authored 340 papers receiving a total of 29.1k indexed citations (citations by other indexed papers that have themselves been cited), including 198 papers in Molecular Biology, 68 papers in Oncology and 50 papers in Cancer Research. Recurrent topics in Bengt Westermark's work include RNA Interference and Gene Delivery (39 papers), Cell Adhesion Molecules Research (30 papers) and Glioma Diagnosis and Treatment (27 papers). Bengt Westermark is often cited by papers focused on RNA Interference and Gene Delivery (39 papers), Cell Adhesion Molecules Research (30 papers) and Glioma Diagnosis and Treatment (27 papers). Bengt Westermark collaborates with scholars based in Sweden, United States and Belgium. Bengt Westermark's co-authors include Carl‐Henrik Heldin, Åke Wasteson, Monica Nistér, Christer Betsholtz, Lena Claesson‐Welsh, Jan Pontén, Annet Hammacher, Ann Johnsson, C H Heldin and Lene Uhrbom and has published in prestigious journals such as Nature, Science and Cell.

In The Last Decade

Bengt Westermark

340 papers receiving 27.7k citations

Hit Papers

Mechanism of Action and In Vivo Role of Platelet-Deri... 1982 2026 1996 2011 1999 1983 1984 1986 1988 500 1000 1.5k
What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

  1. Mechanism of Action and In Vivo Role of Platelet-Derived Growth Factor
    1999 2.0k citations Carl‐Henrik Heldin, Bengt Westermark profile →
  2. Platelet-derived growth factor is structurally related to the putative transforming protein p28sis of simian sarcoma virus
    1983 1.3k citations Åke Wasteson, Bengt Westermark et al. profile →
  3. Growth factors: Mechanism of action and relation to oncogenes
    1984 738 citations Carl‐Henrik Heldin, Bengt Westermark profile →
  4. cDNA sequence and chromosomal localization of human platelet-derived growth factor A-chain and its expression in tumour cell lines
    1986 684 citations Christer Betsholtz, Carl‐Henrik Heldin et al. profile →
  5. A role for platelet-derived growth factor in normal gliogenesis in the central nervous system
    1988 642 citations Bengt Westermark et al. profile →
  6. Stimulation of tyrosine-specific phosphorylation by platelet-derived growth factor
    1982 596 citations Bengt Westermark, Åke Wasteson et al. profile →
  7. Platelet-derived growth factor and its receptors in human glioma tissue: expression of messenger RNA and protein suggests the presence of autocrine and paracrine loops.
    1992 558 citations Carl‐Henrik Heldin, Bengt Westermark et al. PubMed profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Bengt Westermark Sweden 86 16.4k 5.4k 4.2k 4.0k 3.5k 340 29.1k
Werner Risau Germany 84 27.2k 1.7× 6.0k 1.1× 9.3k 2.2× 4.9k 1.2× 3.0k 0.9× 149 38.3k
A. Ullrich Germany 92 22.5k 1.4× 9.0k 1.7× 2.6k 0.6× 3.8k 0.9× 4.3k 1.2× 193 33.0k
Lena Claesson‐Welsh Sweden 87 22.2k 1.4× 6.9k 1.3× 5.8k 1.4× 4.8k 1.2× 3.5k 1.0× 256 32.3k
Ann M. Dvořàk United States 87 13.7k 0.8× 4.1k 0.8× 4.4k 1.1× 3.2k 0.8× 8.4k 2.4× 330 30.5k
Paolo M. Comoglio Italy 104 19.9k 1.2× 8.5k 1.6× 4.6k 1.1× 4.8k 1.2× 3.4k 1.0× 403 35.5k
Christer Betsholtz Sweden 100 28.8k 1.8× 7.9k 1.4× 6.2k 1.5× 6.5k 1.6× 4.6k 1.3× 327 52.3k
Patrìcia A. D'Amore United States 86 17.0k 1.0× 3.6k 0.7× 3.9k 0.9× 3.0k 0.8× 2.5k 0.7× 233 30.0k
Karl Tryggvason Sweden 96 15.1k 0.9× 4.8k 0.9× 6.8k 1.6× 4.9k 1.2× 4.1k 1.2× 384 34.3k
Denis Gospodarowicz United States 84 18.3k 1.1× 3.1k 0.6× 4.9k 1.2× 5.9k 1.5× 1.7k 0.5× 232 29.0k
Michael Klagsbrun United States 103 26.1k 1.6× 8.1k 1.5× 6.8k 1.6× 8.5k 2.1× 3.8k 1.1× 272 38.9k

Countries citing papers authored by Bengt Westermark

Since Specialization
Citations

This map shows the geographic impact of Bengt Westermark's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Bengt Westermark with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Bengt Westermark more than expected).

Fields of papers citing papers by Bengt Westermark

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Bengt Westermark. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Bengt Westermark. The network helps show where Bengt Westermark may publish in the future.

Co-authorship network of co-authors of Bengt Westermark

This figure shows the co-authorship network connecting the top 25 collaborators of Bengt Westermark. A scholar is included among the top collaborators of Bengt Westermark based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Bengt Westermark. Bengt Westermark is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Niklasson, Mia, et al.. (2025). p21-Dependent Senescence Induction by BMP4 Renders Glioblastoma Cells Vulnerable to Senolytics. International Journal of Molecular Sciences. 26(9). 3974–3974. 1 indexed citations
2.
Liu, Jianping, Liqun He, Lars Muhl, et al.. (2021). A human cell type similar to murine central nervous system perivascular fibroblasts. Experimental Cell Research. 402(2). 112576–112576. 7 indexed citations
3.
Tanabe, Ryo, Kohei Miyazono, Tomoki Todo, et al.. (2021). PRRX1 induced by BMP signaling decreases tumorigenesis by epigenetically regulating glioma‐initiating cell properties via DNA methyltransferase 3A. Molecular Oncology. 16(1). 269–288. 6 indexed citations
4.
Johansson, Patrik, et al.. (2020). Growth-Inhibitory Activity of Bone Morphogenetic Protein 4 in Human Glioblastoma Cell Lines Is Heterogeneous and Dependent on Reduced SOX2 Expression. Molecular Cancer Research. 18(7). 981–991. 10 indexed citations
5.
Jin, Zhe, Amol K. Bhandage, Sergiy V. Korol, et al.. (2014). Etomidate, propofol and diazepam potentiate GABA-evoked GABAA currents in a cell line derived from human glioblastoma. European Journal of Pharmacology. 748. 101–107. 18 indexed citations
6.
Bergström, Tobias, Per‐Henrik Edqvist, Anders Lundequist, et al.. (2013). Glioma‐derived macrophage migration inhibitory factor (MIF) promotes mast cell recruitment in a STAT5‐dependent manner. Molecular Oncology. 8(1). 50–58. 36 indexed citations
7.
Erlandsson, Anna, Karin Brännvall, Sigrun Gustafsdottir, Bengt Westermark, & Karin Forsberg‐Nilsson. (2006). Autocrine/Paracrine Platelet-Derived Growth Factor Regulates Proliferation of Neural Progenitor Cells. Cancer Research. 66(16). 8042–8048. 50 indexed citations
8.
Andræ, Johanna, Erik Bongcam‐Rudloff, Inga Hansson, et al.. (2001). A 1.8kb GFAP-promoter fragment is active in specific regions of the embryonic CNS. Mechanisms of Development. 107(1-2). 181–185. 23 indexed citations
9.
Afrakhte, Mozhgan, et al.. (1996). Production of cell‐associated PDGF‐AA by a human sarcoma cell line: evidence for a latent autocrine effect. International Journal of Cancer. 68(6). 802–809. 1 indexed citations
10.
Afrakhte, Mozhgan, et al.. (1996). Production of cell-associated PDGF-AA by a human sarcoma cell line: evidence for a latent autocrine effect. International Journal of Cancer. 68(6). 802–809. 16 indexed citations
11.
12.
Lehtola, Laura, Monica Nistér, Erkki Hölttä, Bengt Westermark, & Kari Alitalo. (1991). Down-regulation of cellular platelet-derived growth factor receptors induced by an activated neu receptor tyrosine kinase.. PubMed. 2(8). 651–661. 3 indexed citations
13.
Paulsson, Ylva, M P Beckmann, Bengt Westermark, & Carl‐Henrik Heldin. (1988). Density-Dependent Inhibition of Cell Growth by Transforming Growth Factor-β1 in Normal Human Fibroblasts. Growth Factors. 1(1). 19–27. 48 indexed citations
14.
Mäkelä, Tomi P., Riitta Alitalo, Ylva Paulsson, et al.. (1987). Regulation of Platelet-Derived Growth Factor Gene Expression by Transforming Growth Factor β and Phorbol Ester in Human Leukemia Cell Lines. Molecular and Cellular Biology. 7(10). 3656–3662. 14 indexed citations
15.
Wasteson, Åke, Bengt Glimelius, Christer Busch, et al.. (1977). Effect of a platelet endoglycosidase on cell surface associated heparan sulphate of human cultured endothelial and glial cells. Thrombosis Research. 11(3). 309–321. 84 indexed citations
16.
Sievertsson, Hans, Linda Fryklund, Knut Uthne, Kerstin Hall, & Bengt Westermark. (1975). Isolation and Chemistry of Human Somatomedins A and B. PubMed. 8. 47–60. 20 indexed citations
17.
Wasteson, Åke, Bengt Westermark, & Knut Uthne. (1975). Somatomedin A and B: Demonstration of Two Different Somatomedinlike Components in Human Plasma. PubMed. 8. 101–113. 7 indexed citations
18.
Lundgren, Erik, et al.. (1974). Isozyme Variations in Human Cells Grown <i>in vitro</i>. Human Heredity. 24(2). 186–193. 4 indexed citations
19.
Beckman, G., L. Beckman, Jan Pontén, & Bengt Westermark. (1971). G-6-PD and PGM Phenotypes of 16 Continuous Human Tumor Cell Lines. Human Heredity. 21(3). 238–241. 46 indexed citations
20.
Beckman, L., Erik Lundgren, Jan Pontén, & Bengt Westermark. (1971). Isozyme Variations in Human Cells Grown <i>in vitro</i>. Human Heredity. 21(5). 500–503. 11 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Werner Risau Breakdown of academic impact, for papers by A. Ullrich Breakdown of academic impact, for papers by Lena Claesson‐Welsh Breakdown of academic impact, for papers by Ann M. Dvořàk Breakdown of academic impact, for papers by Paolo M. Comoglio Breakdown of academic impact, for papers by Christer Betsholtz Breakdown of academic impact, for papers by Patrìcia A. D'Amore Breakdown of academic impact, for papers by Karl Tryggvason Breakdown of academic impact, for papers by Denis Gospodarowicz Breakdown of academic impact, for papers by Michael Klagsbrun
Rankless by CCL
2026